Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Agilent Technologies, Inc. (A) vs IQVIA Holdings Inc. (IQV)

Agilent Technologies, Inc. and IQVIA Holdings Inc. are both Diagnostics & Research companies. Agilent Technologies, Inc. and IQVIA Holdings Inc. are of similar size ($49.0B and $45.3B). IQVIA Holdings Inc. trades at the lower P/E: 33.3× against 33.9×. Agilent Technologies, Inc. grew revenue faster over the last twelve months: 8.60% against 8.17%. Agilent Technologies, Inc. has the higher net margin (19.5% vs 8.10%) and the higher return on invested capital (11.1% vs 6.80%). Across the 22 metrics below, Agilent Technologies, Inc. leads on 11 and IQVIA Holdings Inc. on 11.

Valuation

Metric A IQV Diagnostics & Research median
P/E 33.95 33.26 33.95
P/S 6.61 2.64 4.87
P/B 6.62 7.13 3.12
Price to free cash flow 38.40 19.88 34.02
EV/EBITDA 26.50 17.27 25.20
EV/Sales 6.87 3.46 5.66
Earnings yield 2.95% 3.01% (1.75%)
Free cash flow yield 2.60% 5.03% (0.13%)

Profitability

Metric A IQV Diagnostics & Research median
Gross margin 53.83% 32.97% 50.89%
Operating margin 22.23% 12.95% (8.57%)
Net margin 19.53% 8.10% (6.37%)
Free cash flow margin 17.19% 13.30% 0.00%
Return on equity 20.97% 22.75% (2.92%)
Return on assets 11.00% 4.70% (6.71%)
Return on invested capital 11.07% 6.80% 0.00%

Growth

Metric A IQV Diagnostics & Research median
Revenue growth (TTM) 8.60% 8.17% 7.69%
EPS growth (last fiscal year) 3.16% 4.67% —
Revenue growth, 5-year CAGR 5.41% 7.50% 7.40%
Net income growth, 5-year CAGR 12.63% 37.27% 0.00%

Health

Metric A IQV Diagnostics & Research median
Debt to equity 0.50 2.54 0.11
Current ratio 2.05 0.71 2.02
Net debt to EBITDA 0.71 4.06 0.78

Dividend

Metric A IQV Diagnostics & Research median
Dividend yield 0.70% — 0.70%
Payout ratio 0.23 0.00 0.00

Size

Metric A IQV Diagnostics & Research median
Market cap 49.02b 45.27b 2.56b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack